drugset / Trial / NCT01037036

A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG

NCT01037036

Phase 2 Completed 15 enrolled Mati Therapeutics Inc. QLT Inc. · collab
NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to investigate how the intraocular pressure (IOP)-lowering effect of the L-PPDS is altered by adjunctive Xalatan therapy.

Timeline

Start
2009-12
Primary completion
2010-04
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Latanoprost Small molecule